InterCure Ltd.
INCR
$1.10
$0.065.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.56M | 20.85M | 18.17M | 17.98M | 15.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.56M | 20.85M | 18.17M | 17.98M | 15.28M |
| Cost of Revenue | 21.48M | 20.78M | 12.55M | 12.42M | 15.23M |
| Gross Profit | 73.70K | 71.20K | 5.62M | 5.56M | 52.80K |
| SG&A Expenses | 8.38M | 8.11M | 5.77M | 5.71M | 8.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2.89M | 2.80M | -987.80K | -977.80K | 4.69M |
| Total Operating Expenses | 32.79M | 31.71M | 17.36M | 17.18M | 28.54M |
| Operating Income | -11.23M | -10.86M | 810.40K | 802.10K | -13.26M |
| Income Before Tax | -6.43M | -6.22M | -321.00K | -317.70K | -11.99M |
| Income Tax Expenses | -1.05M | -1.02M | -67.80K | -67.10K | -2.16M |
| Earnings from Continuing Operations | -5.38M | -5.20M | -253.20K | -250.60K | -9.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 148.50K | 143.70K | 15.10K | 14.90K | 480.80K |
| Net Income | -5.23M | -5.06M | -238.10K | -235.70K | -9.35M |
| EBIT | -11.23M | -10.86M | 810.40K | 802.10K | -13.26M |
| EBITDA | -10.70M | -10.35M | 1.99M | 1.97M | -12.82M |
| EPS Basic | -0.10 | -0.10 | 0.00 | 0.00 | -0.21 |
| Normalized Basic EPS | -0.15 | -0.15 | 0.00 | 0.00 | -0.20 |
| EPS Diluted | -0.10 | -0.10 | 0.00 | 0.00 | -0.21 |
| Normalized Diluted EPS | -0.15 | -0.15 | 0.00 | 0.00 | -0.20 |
| Average Basic Shares Outstanding | 50.69M | 50.69M | 56.80M | 56.80M | 43.97M |
| Average Diluted Shares Outstanding | 50.69M | 50.69M | 56.80M | 56.80M | 43.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |